Condition
Leukemia, Myelogenous, Chronic, BCR-ABL Positive clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Leukemia, Myelogenous, Chronic, BCR-ABL Positive clinical trials that are recruiting, at sites in 31 countries (most in France (2), Germany (2), Italy (2)). By phase: Phase 1/2 (1), Phase 4 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 31Countries
All recruiting trials (2)
-
Evaluating TERN-701 for Chronic Myeloid Leukemia
This study is testing a new drug called TERN-701 to see if it can safely help people with chronic myeloid leukemia who have already been treated.
-
Long-term safety treatment for chronic myelogenous leukemia patients
This study is testing the long-term safety of a medication called asciminib for patients with chronic myelogenous leukemia who have already been part of another study.
Related topics
Quick answers
How many Leukemia, Myelogenous, Chronic, BCR-ABL Positive clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 31 countries. The most sites are in France (2 trials), Germany (2 trials), Italy (2 trials), South Korea (2 trials), Spain (2 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 1, Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.